In November, it was announced that AmeriLife and Wamberg Genomic Advisors partnered to grant employees and brokers with the Cancer Guardian™​ benefits starting in 2020. These benefits are the first of their kind to provide members with exceptional care during a very difficult time of handling and maintaining cancer. Cancer Guardian™ includes advanced genomic testing for members who might have a family history of high-risk cancers. “Cancer, unfortunately, strikes us all – whether it be directly, a family member, friend or colleague,” said Scott Perry, CEO of AmeriLife.

Clicking third-party links will open a new tab and will take you away from AmeriLife.com. AmeriLife does not control the linked sites’ content or link.